Role of the Glutamatergic System in Nicotine Dependence: Implications for the Discovery and Development of New Pharmacological Smoking Cessation Therapies

Author： Liechti Matthias E.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.9, 2008-01, pp. : 705-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bupropion and nicotine inhaler therapies for smoking cessation

By  

Inpharma, Vol. 1, Iss. 1580, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Recent developments for smoking cessation and treatment of nicotine dependence

By Balbani Aracy PS   Montovani Jair C  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 3, 2007-03 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of Nicotine Dependence and Impact on Smoking Cessation

By  

Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. : 178-189

Bentham Science Publishers

Access to resources Recommend Favorite

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease

By Wagena E.J.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 381-403

Adis International

Access to resources Recommend Favorite

A nicotine vaccine for smoking cessation

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite